The Histone Deacetylase Inhibitor OBP-801 Exhibits Potent Anti-Tumor Activity Against Neuroblastoma

被引:0
|
作者
Kaneda, Daisuke [1 ]
Kikuchi, Ken [1 ,2 ]
Yagyu, Shigeki [1 ]
Iehara, Tomoko [1 ]
Sakai, Toshiyuki [3 ]
Hosoi, Hajime [1 ]
机构
[1] Kyoto Prefectural Univ Med, Grad Sch Med Sci, Dept Pediat, Kyoto, Japan
[2] Uji Takeda Hosp, Dept Pediat, Kyoto, Japan
[3] Kyoto Prefectural Univ Med, Grad Sch Med Sci, Dept Mol Targeting Canc Prevent, Kyoto, Japan
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
OS6-1-2
引用
收藏
页码:S40 / S41
页数:2
相关论文
共 50 条
  • [41] The Anti-Tumor Histone Deacetylase Inhibitor SAHA and the Natural Flavonoid Curcumin Exhibit Synergistic Neuroprotection against Amyloid-Beta Toxicity
    Meng, Jia
    Li, Yan
    Camarillo, Cynthia
    Yao, Yue
    Zhang, Yina
    Xu, Chun
    Jiang, Lihong
    PLOS ONE, 2014, 9 (01):
  • [42] The Glutaminase Inhibitor Compound 968 Exhibits Potent In vitro and In vivo Anti-tumor Effects in Endometrial Cancer
    Guo, Hui
    Li, Wanhu
    Pan, Guoyou
    Wang, Cong
    Li, Dapeng
    Liu, Naifu
    Sheng, Xiugui
    Yuan, Lingqin
    ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY, 2023, 23 (02) : 210 - 221
  • [43] The topoisomerase I inhibitor gimatecan exhibits anti-tumor activity against malignant glioma xenografts as single agent and in combination
    Vassal, G.
    Hamelin, N.
    Opolon, P.
    Versace, R.
    Geoerger, B.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [44] A potent trifluoromethyl ketone histone deacetylase inhibitor exhibits class-dependent mechanism of action
    Madsen, Andreas S.
    Olsen, Christian A.
    MEDCHEMCOMM, 2016, 7 (03) : 464 - 470
  • [45] A PD-1 peptide antagonist exhibits potent anti-tumor and immune regulatory activity
    Tao, Huimin
    Cheng, Lu
    Liu, Lihua
    Wang, Hong
    Jiang, Zhijie
    Qiang, Xu
    Xing, Lijun
    Xu, Yifeng
    Cai, Xinying
    Yao, Jing
    Wang, Min
    Qiu, Zheng
    CANCER LETTERS, 2020, 493 : 91 - 101
  • [46] SOCS-3 protein exhibits potent anti-tumor activity in malignant pleural mesothelioma
    Iwahori, Kota
    Serada, Satoshi
    Fujimoto, Minoru
    Kishimoto, Mitsu
    Naka, Tetsuji
    JOURNAL OF THORACIC ONCOLOGY, 2009, 4 (09) : S764 - S765
  • [47] Histone deacetylase inhibitor trichostatin A and autophagy inhibitor chloroquine synergistically exert anti-tumor activity in H-ras transformed breast epithelial cells
    Gao, Liang
    Sun, Xin
    Zhang, Qi
    Chen, Xiaochen
    Zhao, Tongwei
    Lu, Liqing
    Zhang, Jianbin
    Hong, Yupeng
    MOLECULAR MEDICINE REPORTS, 2018, 17 (03) : 4345 - 4350
  • [48] Histone Deacetylase Inhibitor Trichostatin A Enhances Anti-tumor Effects of Docetaxel or Erlotinib in A549 Cell Line
    Zhang, Qun-Cheng
    Jiang, Shu-Juan
    Zhang, Song
    Ma, Xiao-Bin
    ASIAN PACIFIC JOURNAL OF CANCER PREVENTION, 2012, 13 (07) : 3471 - 3476
  • [49] Histone deacetylase inhibitor augments anti-tumor effect of gemcitabine and pegylated interferon-α on pancreatic cancer cells
    Iwahashi, Shuichi
    Shimada, Mitsuo
    Utsunomiya, Tohru
    Morine, Yuji
    Imura, Satoru
    Ikemoto, Tetsuya
    Mori, Hiroki
    Hanaoka, Jun
    Sugimoto, Koji
    Saito, Yu
    INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2011, 16 (06) : 671 - 678
  • [50] HISTONE DEACETYLASE INHIBITOR TRICHOSTATIN A ENHANCES ANTI-TUMOR EFFECT OF DOCETAXEL OR ERLOTINIB IN A549 CELL LINE
    Jiang, S.
    RESPIROLOGY, 2011, 16 : 164 - 164